Bioventus Inc.

Bioventus Inc. is a global medical device company that helps patients recover from musculoskeletal challenges and pain. The company operates through two reporting segments: U.S., which generated 88% of total net sales, and International, which generated 12% of total net sales during the fiscal year ended December 31, 2025. Its products are organized into three businesses based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. The Pain Treatments business includes Knee Osteoarthritis (KOA) products, which are hyaluronic acid (HA) injections for pain relief, and the XCELL Platelet-Rich Plasma (PRP) system distributed in the U.S. This segment also includes Peripheral Nerve Stimulation (PNS) products for acute, temporary, and chronic pain. The Surgical Solutions business offers Ultrasonics for precision bone resection in degenerative spine conditions, spinal deformities, brain tumors, and pathologies of the liver and other organs. It also includes Bone Graft Substitutes (BGS) products that aid bone fusion after surgery. The Restorative Therapies business focuses on Fracture Care, providing low-intensity pulse ultrasound for bone fractures that do not heal with traditional methods.